Natural Products Expo West was supposed to be a launching pad for many new products. With the cancellation of the show and the many other coronavirus-related dislocations, natural products companies are scrambling to adapt.
The impact of Coronavirus on the manufacturing supply chain could affect worldwide revenue to the tune of €14 trillion this year as the nutrition industry sets about assessing the long-term ramifications.
A panel of science researchers has put up a list of key findings on the role of micronutrients in supporting the immune system, which firms can tap on to educate the consumers in light of the coronavirus outbreak.
One of the pioneers of the space topped $53 million in annual revenue, but also recorded a loss as the founders cashed out. The firm also said regulatory uncertainty has increased competition as numerous small brands crowd into the field.
Chinese health foods giant BY-HEALTH's FY19 revenue jumped 20.94% to hit RMB$5.2bn (US$748m), however performance from its Australian subsidiary Life-Space failed to meet expectations due to changes in China’s e-commerce law.
The FTC is revisiting its Endorsement Guides and seeking public comment on what changes might be needed as it initiates an enforcement action on health claims made by influencers.
Event organisers are to postpone this year’s Vitafoods Europe in response to the ongoing COVID-19 situation that has already forced several nutraceutical industry events to be rescheduled.
The a2 Milk Company said revenue from China was “above expectations” in Jan and Feb, but the ongoing COVID-19 outbreak had brought uncertainty to consumer demand and supply chain.
Drugs manufacturer Stada is to acquire fifteen of GlaxoSmithKline’s (GSK) consumer healthcare brands in a deal that includes its Cetebe vitamin C supplements.
A mega-merger between International Flavors & Fragrances Inc (IFF) and DuPont nutrition & biosciences unit will create a new industry giant worth more than $45 billion (€40.4 billion), say those involved in the deal.
The year 2019 was a solid one for the omega-3 business, with sales remaining steady. In the US, the market was mostly flat, but strong regional growth in the Asia-Pacific region and other emerging markets led to category growth overall.
